Measuring antigenicity and immunogenicity of mouse tumors is typically done directly through transplantation studies (3, 4) and, for years, has been used to identify tumor-specific peptides that are processed and presented by MHC to generate tumor-rejecting T cell responses (53). The gene discussed is HLA-C; the disease is neoplasm.